/Green Mellen

About Green Mellen

This author has not yet filled in any details.
So far Green Mellen has created 20 blog entries.

FisherBroyles and the Law Firm 2.0® Business Model it Created was Cited by The American Lawyer as “A Growing Threat to Big Law”

Stay-at-Home-Rainmakers: A Growing Threat to Big Law Cloud-based law firms still face skepticism from some pockets of the legal market. But there are signs that they are becoming stiffer competition for Big Law. View the full article here.

FisherBroyles Partner, Geoffrey Goodale, chosen to participate in a roundtable discussion on sanctions compliance and enforcement developments, published in the April 2017 issue of Financier Worldwide

Geoffrey Goodale, a Partner in the Washington, DC office of FisherBroyles and Co-Chair of the ABA Section of International Law’s Export Controls and Economic Sanctions Committee, was one of several top experts chosen to participate in a roundtable discussion on sanctions compliance and enforcement developments that has been published in the April 2017 issue of [...]

Hospice Companies Caught in Kickback Scheme, Pay $12 Million to Settle Allegations

Last month, we issued a client alert on the rising number of fraud, waste, and abuse cases being seen in the hospice care industry. Today we provide yet another example of the rising tide of hospice-related fraudulent schemes that the government is actively uncovering and prosecuting. This past Tuesday, the U.S. Attorney's Office, Northern District [...]

Former WellCare Executives Agree to Restitution and Civil Payments $ 26 million settlement wraps up Medicaid fraud case

In 2013, two former WellCare Health Plans Inc. executives (WellCare) were found guilty of health care fraud for their parts in devising and carrying out a fraudulent scheme that deceived the Florida Agency for Health Care Administration (AHCA), the Florida Healthy Kids Corporation (Healthy Kids), and WellCare's investors by retaining over $40 million in health [...]

Best Practices Regarding Pharmacy Audit Response

Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to address these issues when running your pharmacy.  Please [...]

Earnouts: Bridging the Valuation Gap in Mergers and Acquisitions

An earnout is a mechanism used in business acquisitions that allows seller to receive additional post-closing payments over time depending on the performance of the company, business unit or asset transferred to buyer (the “Acquired Asset”). Earnouts allow a transaction to move forward when seller places a higher valuation on the Acquired Assets than buyer.Generally, [...]

FisherBroyles partner Chris Pey quoted in the Wall Street Journal in its coverage of the US/EU beef hormone trade dispute

FisherBroyles partner Chris Pey was quoted in the Wall Street Journal in its coverage of the US/EU beef hormone trade dispute. Mr. Pey represented the makers of Roquefort cheese as they try to convince the US Trade Representative to not select them for retaliatory tariffs in the beef hormone dispute. “It is going to hurt [...]

FisherBroyles Bankruptcy Partner, Hollace Cohen’s Article Published in Leading Law Review

FisherBroyles bankruptcy partner Hollace Cohen’s important article was published in the February 2017 edition of the Norton Journal of Bankruptcy Law and Practice. Ms. Cohen’s article, entitled “Is the Absolute Priority Rule Alive and Well? Jevic Threatens the Rule and Other Core Bankruptcy Principles”, criticizes the controversial decision of the U.S. Court of Appeals for [...]

Compounding Pharmacies Face Uphill Battle in FDA Investigations

A small compounding pharmacy in southeastern Pennsylvania has come to learn just how frustrating it can be to undergo an FDA investigation. Dorneyville Pharmacy (Dorneyville) in South Whitehall Township, Pennsylvania, underwent an FDA inspection from December 9, 2015 through January 7, 2016, after which the FDA inspector issued a “Form FDA 483” to the Dorneyville [...]